Updated Results of a Phase 2 Study of Modified Lenalidomide, Bortezomib, and Dexamethasone (Rvd-Lite) in Transplant-Ineligible Multiple Myeloma
Blood(2019)
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined